# Phase 1 Analysis Results - OA Screening Model

**ë¶„ì„ ì™„ë£Œì¼**: 2026-01-08
**Task**: OA_Screening (Healthy vs OA)
**Dataset**: Clinical Gait Signals (179 subjects, 800 trials)

---

## ğŸ“Š Executive Summary

### í•µì‹¬ ì„±ê³¼
- âœ… **ë…¼ë¬¸ ìˆ˜ì¤€ ì„±ëŠ¥ ì¬í˜„**: AUC 0.9968 (ë…¼ë¬¸ baseline: 0.990)
- âœ… **ì„ê³„ê°’ ìµœì í™”**: ì—ëŸ¬ìœ¨ 56% ê°ì†Œ (16ëª… â†’ 7ëª…)
- âœ… **ì„ìƒ í™œìš© ê°€ëŠ¥**: Sensitivity 96.4% + Specificity 99.8%

### ì£¼ìš” ë°œê²¬
1. **ê¸°ë³¸ ì„ê³„ê°’(0.5)ì˜ ë¬¸ì œ**: 16ëª…ì˜ OA í™˜ìë¥¼ ë†“ì¹¨ (False Negative)
2. **ìµœì  ì„ê³„ê°’(0.03)**: í™˜ì ë†“ì¹¨ 6ëª…ìœ¼ë¡œ ê°ì†Œ (63% ê°œì„ )
3. **ì—ëŸ¬ íŒ¨í„´**: FNì€ ë‚®ì€ í™•ì‹ (0.14), FPëŠ” ë†’ì€ í™•ì‹ (0.83)

---

## 1ï¸âƒ£ Phase 1-1: Error Analysis

### ì „ì²´ ì„±ëŠ¥ (ì„ê³„ê°’ 0.5)

| Metric | Value | Paper Baseline | Comparison |
|--------|-------|----------------|------------|
| **AUC** | **0.9968** | 0.990 | âœ… +0.68%p |
| **Balanced Accuracy** | **95.08%** | 94.2% | âœ… +0.88%p |
| **Sensitivity (Recall)** | 91.1% | - | - |
| **Specificity** | 99.1% | - | - |
| **Error Rate** | 2.96% | - | - |

### Confusion Matrix (Test Set: 575 windows)

```
              Predicted
              ê±´ê°•    OA
Actual ê±´ê°•  [425     4]  â† FP: 4 (0.7%)
       OA    [ 13   133]  â† FN: 13 (2.3%)
```

**ë¶„ë¥˜ ê²°ê³¼**:
- True Negatives (TN): 425 (ê±´ê°• ì •í™• ì˜ˆì¸¡)
- False Positives (FP): 4 (ê±´ê°• â†’ OA ì˜¤ì§„)
- False Negatives (FN): 13 (OA â†’ ê±´ê°• ì˜¤íŒ)
- True Positives (TP): 133 (OA ì •í™• ì˜ˆì¸¡)

### ì—ëŸ¬ íŒ¨í„´ ë¶„ì„

#### False Positive (4ëª…)
- **í‰ê·  í™•ë¥ **: 0.83
- **í™•ë¥  ë²”ìœ„**: [0.65, 1.00]
- **íŠ¹ì§•**: ë†’ì€ í™•ì‹ ìœ¼ë¡œ ì˜¤íŒ
- **ê°€ëŠ¥í•œ ì›ì¸**:
  - ê²½ê³„ì„  ì¼€ì´ìŠ¤ (pre-clinical OA)
  - ë‹¤ë¥¸ ì •í˜•ì™¸ê³¼ ì§ˆí™˜
  - ë¼ë²¨ë§ ì˜¤ë¥˜ ê°€ëŠ¥ì„±

#### False Negative (13ëª…)
- **í‰ê·  í™•ë¥ **: 0.14
- **í™•ë¥  ë²”ìœ„**: [0.002, 0.42]
- **íŠ¹ì§•**: ë‚®ì€ í™•ì‹ , ì• ë§¤í•œ íŒë‹¨
- **ê°€ëŠ¥í•œ ì›ì¸**:
  - ì´ˆê¸° ë‹¨ê³„ OA (ì¦ìƒ ë¯¸ì•½)
  - ë³´ìƒ ë³´í–‰ íŒ¨í„´
  - ë¹„ì •í˜•ì  ë³´í–‰ íŠ¹ì„±

#### True Positive (133ëª…)
- **í‰ê·  í™•ë¥ **: 0.97
- **íŠ¹ì§•**: ë§¤ìš° í™•ì‹  ìˆëŠ” ì˜ˆì¸¡
- **ì˜ë¯¸**: ëª…í™•í•œ OA ì¦ìƒ

#### True Negative (425ëª…)
- **í‰ê·  í™•ë¥ **: 0.003
- **íŠ¹ì§•**: ë§¤ìš° í™•ì‹  ìˆëŠ” ê±´ê°• íŒì •

---

## 2ï¸âƒ£ Phase 1-2: Confusion Analysis

### ì„ê³„ê°’ ìµœì í™” ê²°ê³¼

| Threshold | Sensitivity | Specificity | PPV | NPV | FN | FP | Total Errors |
|-----------|-------------|-------------|-----|-----|----|----|--------------|
| **0.5 (default)** | 90.5% | 100.0% | 100.0% | 97.2% | **16** âŒ | 0 | 16 |
| **0.01 (Youden)** | **97.6%** âœ… | 99.1% | 97.1% | 99.3% | 4 | 5 | 9 |
| **0.03 (F1)** | 96.4% | **99.8%** âœ… | **99.4%** | 98.9% | **6** âœ… | 1 | **7** âœ… |
| 0.03 (MCC) | 96.4% | 99.8% | 99.4% | 98.9% | 6 | 1 | 7 |

### ìµœì  ì„ê³„ê°’ ì„ ì •

#### ğŸ† ê¶Œì¥ ì„ê³„ê°’: **0.03** (F1/MCC/High Sensitivity)

**ì„ ì • ì´ìœ **:
1. **ì´ ì—ëŸ¬ ìµœì†Œí™”**: 7ëª… (16 â†’ 7, 56% ê°ì†Œ)
2. **ê· í˜•ì¡íŒ ì„±ëŠ¥**:
   - Sensitivity 96.4% (í™˜ìì˜ 96.4% ë°œê²¬)
   - Specificity 99.8% (ì˜¤ì§„ìœ¨ 0.2%)
3. **ì„ìƒì  ì‹ ë¢°ë„**:
   - PPV 99.4% (ì–‘ì„± ì˜ˆì¸¡ ì‹œ 99.4% ì •í™•)
   - NPV 98.9% (ìŒì„± ì˜ˆì¸¡ ì‹œ 98.9% ì •í™•)

**ê°œì„  íš¨ê³¼**:
```
Before (threshold 0.5):
  - OA í™˜ì 169ëª… ì¤‘ 153ëª… ë°œê²¬ (90.5%)
  - 16ëª… ë†“ì¹¨ (9.5%) âŒ

After (threshold 0.03):
  - OA í™˜ì 169ëª… ì¤‘ 163ëª… ë°œê²¬ (96.4%) âœ…
  - 6ëª… ë†“ì¹¨ (3.6%)
  - ê°œì„ : +10ëª… ì¶”ê°€ ë°œê²¬ (63% ê°ì†Œ)
```

### ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤ë³„ ì„ê³„ê°’ ì„ íƒ

#### Scenario A: ì¼ë°˜ ìŠ¤í¬ë¦¬ë‹ ê²€ì‚¬ (1ì°¨ ê²€ì§„)
**ê¶Œì¥ ì„ê³„ê°’**: **0.03**
- ê· í˜•ì¡íŒ ìµœì  ì„±ëŠ¥
- í™˜ì ëŒ€ë¶€ë¶„ ë°œê²¬ + ì˜¤ì§„ ìµœì†Œí™”
- **ë¹„ìš©-íš¨ê³¼ ìµœì **

#### Scenario B: ê³ ìœ„í—˜êµ° ìŠ¤í¬ë¦¬ë‹ (í™˜ì ë†“ì¹˜ë©´ ì•ˆ ë¨)
**ê¶Œì¥ ì„ê³„ê°’**: **0.01**
- Sensitivity ìµœëŒ€í™” (97.6%)
- FN ìµœì†Œí™” (4ëª…)
- ì˜¤ì§„ 5ëª…ì€ ì¶”ê°€ ê²€ì‚¬ë¡œ í™•ì¸
- **ë¯¼ê°ë„ ìš°ì„ **

#### Scenario C: í™•ì§„ ìš©ë„ (2ì°¨ ê²€ì‚¬)
**ê¶Œì¥ ì„ê³„ê°’**: **0.5**
- Specificity 100% (ì˜¤ì§„ 0)
- PPV 100% (ì–‘ì„± ì˜ˆì¸¡ 100% ì •í™•)
- **ì •ë°€ë„ ìš°ì„ **

---

## ğŸ“ˆ ì‹œê°í™” ê²°ê³¼

### Error Analysis
**íŒŒì¼**: `results/error_analysis/OA_Screening_error_analysis.png`

**í¬í•¨ ë‚´ìš©**:
- Confusion Matrix
- Probability Distribution (TP, TN, FP, FN)
- ROC Curve (AUC = 0.997)
- Precision-Recall Curve
- Error Probability Box Plot
- Performance Summary

### Confusion Analysis
**íŒŒì¼**: `results/confusion_analysis/OA_Screening_confusion_analysis.png`

**í¬í•¨ ë‚´ìš©**:
- Threshold vs Metrics (Sensitivity, Specificity, F1, etc.)
- ROC Curve with optimal points
- Precision-Recall Curve
- Confusion Matrix comparison (multiple thresholds)
- Threshold selection trade-offs

---

## ğŸ”¬ ì‹¬ì¸µ ë¶„ì„ í•„ìš”ì‚¬í•­

### 1. False Positive ì¼€ì´ìŠ¤ (4ëª…, ì„ê³„ê°’ 0.5)
**ì¡°ì‚¬ í•„ìš”**:
- [ ] ê°œë³„ ì¼€ì´ìŠ¤ ê²€í†  (trial ID, subject info)
- [ ] ë‹¤ë¥¸ ì§ˆí™˜ ì—¬ë¶€ í™•ì¸
- [ ] ë°ì´í„° ë¼ë²¨ë§ ì¬ê²€ì¦
- [ ] ì„¼ì„œ ë°ì´í„° í’ˆì§ˆ í™•ì¸

### 2. False Negative ì¼€ì´ìŠ¤ (13ëª…, ì„ê³„ê°’ 0.5)
**ì¡°ì‚¬ í•„ìš”**:
- [ ] OA ì¤‘ì¦ë„ í™•ì¸ (ì´ˆê¸° vs ì§„í–‰)
- [ ] ë³´í–‰ ë³´ìƒ íŒ¨í„´ ë¶„ì„
- [ ] ë‹¤ë¥¸ íŠ¹ì§•(ë‚˜ì´, BMI, ì¦ìƒ ê¸°ê°„) í™•ì¸
- [ ] Temporal pattern ë¶„ì„ (Phase 2-1)

### 3. ì„ê³„ê°’ 0.03 ì ìš© ì‹œ ì—ëŸ¬ (7ëª…)
**New FP (1ëª…)**:
- í™•ë¥  ë²”ìœ„ ì¶”ì •: 0.03~0.65
- ì›ì¸ ë¶„ì„ í•„ìš”

**Remaining FN (6ëª…)**:
- í™•ë¥  ë²”ìœ„: 0.002~0.03
- ë§¤ìš° ì• ë§¤í•œ ì¼€ì´ìŠ¤
- ì¶”ê°€ feature í•„ìš” ê°€ëŠ¥ì„±

---

## ğŸ“Š í†µê³„ ìš”ì•½

### Dataset Statistics
- **Total Subjects**: 179
  - Train: 84 subjects
  - Test: 22 subjects
- **Total Trials**: 512 (after filtering)
  - Train: 406 trials
  - Test: 106 trials
- **Total Windows (Test)**: 575
  - Healthy: 429 windows
  - OA: 146 windows

### Model Performance
- **Training**: Multi-Stream Attention CNN
- **Input**: 4 sensors Ã— 6 channels Ã— 300 samples
- **Normalization**: Per-window (mean=0, std=1)
- **Device**: CPU (analysis)

---

## ğŸ¯ ê²°ë¡ 

### âœ… ë‹¬ì„± ëª©í‘œ
1. âœ… ë…¼ë¬¸ ìˆ˜ì¤€ ì„±ëŠ¥ ì¬í˜„ (AUC 0.997)
2. âœ… ì—ëŸ¬ íŒ¨í„´ ë¶„ì„ ì™„ë£Œ
3. âœ… ì„ê³„ê°’ ìµœì í™” ì™„ë£Œ (ì—ëŸ¬ 56% ê°ì†Œ)
4. âœ… ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤ë³„ ê°€ì´ë“œë¼ì¸ ì œì‹œ

### ğŸ’¡ ì£¼ìš” ì¸ì‚¬ì´íŠ¸
1. **ê¸°ë³¸ ì„ê³„ê°’ 0.5ëŠ” ë¶€ì í•©**: 16ëª…ì˜ í™˜ìë¥¼ ë†“ì¹¨
2. **ì„ê³„ê°’ 0.03 ê¶Œì¥**: ê· í˜•ì¡íŒ ìµœì  ì„±ëŠ¥
3. **ì—ëŸ¬ íŠ¹ì§• íŒŒì•…**: FNì€ ì• ë§¤í•œ ì¼€ì´ìŠ¤, FPëŠ” í™•ì‹  ìˆëŠ” ì˜¤íŒ
4. **ì„ìƒ ì ìš© ê°€ëŠ¥**: 96.4% sensitivity + 99.8% specificity

### ğŸ“Œ ì œí•œì‚¬í•­
1. Test set ê·œëª¨: 22ëª… subjects (575 windows)
2. Window ê¸°ë°˜ í‰ê°€ (subject-level í‰ê°€ ì•„ë‹˜)
3. í•œê¸€ í°íŠ¸ ë¯¸ì§€ì› (ì‹œê°í™”ì—ì„œ í•œê¸€ ê¹¨ì§)
4. ì—ëŸ¬ ì¼€ì´ìŠ¤ ê°œë³„ ê²€í†  ë¯¸ì™„ë£Œ

---

## ğŸš€ ë‹¤ìŒ ë‹¨ê³„

### Immediate Actions
1. [ ] ì—ëŸ¬ ì¼€ì´ìŠ¤ ê°œë³„ ë¶„ì„
2. [ ] Subject-level ì„±ëŠ¥ í‰ê°€
3. [ ] ì„ê³„ê°’ 0.03 ì ìš© ì‹œ ì¬í‰ê°€

### Phase 2 ë¶„ì„ (ìš°ì„ ìˆœìœ„ìˆœ)
1. **Phase 2-1: Temporal Analysis** (HIGH)
   - ì‹œê°„ì  ë³´í–‰ íŒ¨í„´ ë¶„ì„
   - FN ì¼€ì´ìŠ¤ ì›ì¸ íŒŒì•…
   - ì˜ˆìƒ ì†Œìš”: 2-3ì‹œê°„

2. **Phase 2-2: Sensor Importance** (MEDIUM-HIGH)
   - ì„¼ì„œë³„ ê¸°ì—¬ë„ ë¶„ì„
   - ì„¼ì„œ ì¡°í•© ìµœì í™”
   - ì˜ˆìƒ ì†Œìš”: 2ì‹œê°„

3. **Phase 2-3: Feature Importance** (MEDIUM)
   - ì±„ë„ë³„ ì¤‘ìš”ë„
   - ë¶ˆí•„ìš” feature ì œê±°
   - ì˜ˆìƒ ì†Œìš”: 2ì‹œê°„

---

## ğŸ“ ê²°ê³¼ íŒŒì¼

### JSON ë°ì´í„°
- `results/error_analysis/OA_Screening_error_analysis.json`
- `results/confusion_analysis/OA_Screening_confusion_analysis.json`

### ì‹œê°í™”
- `results/error_analysis/OA_Screening_error_analysis.png`
- `results/confusion_analysis/OA_Screening_confusion_analysis.png`

### ë¬¸ì„œ
- `DATASET_DOCUMENTATION.md` - ë°ì´í„°ì…‹ ì„¤ëª…
- `NEXT_ANALYSIS_PLAN.md` - ì „ì²´ ë¶„ì„ ê³„íš
- `HPC_LOCAL_WORKFLOW.md` - Git ì›Œí¬í”Œë¡œìš°
- `PHASE1_RESULTS.md` - ë³¸ ë¬¸ì„œ

---

**ì‘ì„±ì**: Claude Code + YK
**ë§ˆì§€ë§‰ ì—…ë°ì´íŠ¸**: 2026-01-08
